Global Viral Vaccines Market Research Report 2019

Published On: May 2019

Format: PDF

Publisher: QY Research

Pages: 112

Report ID: 965



This report studies the global Viral Vaccines market status and forecast, categorizes the global Viral Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Attenuated Vaccine
Inactivated Vaccine
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital
Pharmaceutical Factory
Research Institute
Other

The study objectives of this report are:
To analyze and study the global Viral Vaccines capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Viral Vaccines manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Viral Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Viral Vaccines Manufacturers
Viral Vaccines Distributors/Traders/Wholesalers
Viral Vaccines Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Viral Vaccines market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Viral Vaccines Market Research Report 2018
1 Viral Vaccines Market Overview
1.1 Product Overview and Scope of Viral Vaccines
1.2 Viral Vaccines Segment by Type (Product Category)
1.2.1 Global Viral Vaccines Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Viral Vaccines Production Market Share by Type (Product Category) in 2017
1.2.3 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Global Viral Vaccines Segment by Application
1.3.1 Viral Vaccines Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Other
1.4 Global Viral Vaccines Market by Region (2013-2025)
1.4.1 Global Viral Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Viral Vaccines (2013-2025)
1.5.1 Global Viral Vaccines Revenue Status and Outlook (2013-2025)
1.5.2 Global Viral Vaccines Capacity, Production Status and Outlook (2013-2025)

2 Global Viral Vaccines Market Competition by Manufacturers
2.1 Global Viral Vaccines Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Viral Vaccines Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Viral Vaccines Production and Share by Manufacturers (2013-2018)
2.2 Global Viral Vaccines Revenue and Share by Manufacturers (2013-2018)
2.3 Global Viral Vaccines Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Viral Vaccines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Viral Vaccines Market Competitive Situation and Trends
2.5.1 Viral Vaccines Market Concentration Rate
2.5.2 Viral Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Viral Vaccines Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Viral Vaccines Capacity and Market Share by Region (2013-2018)
3.2 Global Viral Vaccines Production and Market Share by Region (2013-2018)
3.3 Global Viral Vaccines Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Viral Vaccines Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Viral Vaccines Consumption by Region (2013-2018)
4.2 North America Viral Vaccines Production, Consumption, Export, Import (2013-2018)
4.3 Europe Viral Vaccines Production, Consumption, Export, Import (2013-2018)
4.4 China Viral Vaccines Production, Consumption, Export, Import (2013-2018)
4.5 Japan Viral Vaccines Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Viral Vaccines Production, Consumption, Export, Import (2013-2018)
4.7 India Viral Vaccines Production, Consumption, Export, Import (2013-2018)

5 Global Viral Vaccines Production, Revenue (Value), Price Trend by Type
5.1 Global Viral Vaccines Production and Market Share by Type (2013-2018)
5.2 Global Viral Vaccines Revenue and Market Share by Type (2013-2018)
5.3 Global Viral Vaccines Price by Type (2013-2018)
5.4 Global Viral Vaccines Production Growth by Type (2013-2018)

6 Global Viral Vaccines Market Analysis by Application
6.1 Global Viral Vaccines Consumption and Market Share by Application (2013-2018)
6.2 Global Viral Vaccines Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Viral Vaccines Manufacturers Profiles/Analysis
7.1 GSK
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Viral Vaccines Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 GSK Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Viral Vaccines Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Novartis
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Viral Vaccines Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Novartis Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Pfizer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Viral Vaccines Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Pfizer Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Sanofi
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Viral Vaccines Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Sanofi Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Bayer
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Viral Vaccines Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Bayer Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Zoetis
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Viral Vaccines Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Zoetis Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 AstraZeneca
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Viral Vaccines Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 AstraZeneca Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Johnson
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Viral Vaccines Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Johnson Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 CSL
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Viral Vaccines Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 CSL Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview

8 Viral Vaccines Manufacturing Cost Analysis
8.1 Viral Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Viral Vaccines

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Viral Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Viral Vaccines Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Viral Vaccines Market Forecast (2018-2025)
12.1 Global Viral Vaccines Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Viral Vaccines Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Viral Vaccines Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Viral Vaccines Price and Trend Forecast (2018-2025)
12.2 Global Viral Vaccines Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Viral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Viral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Viral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Viral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Viral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Viral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Viral Vaccines Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Viral Vaccines Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer